StreetInsider.com News Articles

Form 144 Opendoor Technologies Filed by: Radhakrishna Shrisha

Tue, 03 Mar 2026 16:45:00 -0500

si-local-file:///var/storage/secattach/20260303/26102729.html

Form 144 Opendoor Technologies Filed by: Radhakrishna Shrisha

Tue, 03 Mar 2026 16:45:00 -0500

si-local-file:///var/storage/secattach/20260303/26102729.html

Opendoor (OPEN) call put ratio 2.8 calls to 1 put

Mon, 23 Feb 2026 05:21:23 -0500

Opendoor (NASDAQ: OPEN) 30-day option implied volatility is at 83; compared to its 52-week range of 73 to 328. Call put ratio 2.8 calls to 1 put.

SRX Health Solutions raises stake in Opendoor by 30%

Fri, 20 Feb 2026 09:04:57 -0500

SRX Health Solutions raises stake in Opendoor by 30%

SRX Health Solutions raises stake in Opendoor by 30%

Fri, 20 Feb 2026 09:04:57 -0500

SRX Health Solutions raises stake in Opendoor by 30%

SRX Health Solutions raises stake in Opendoor by 30%

Fri, 20 Feb 2026 09:04:57 -0500

SRX Health Solutions raises stake in Opendoor by 30%

SRX Health Solutions raises stake in Opendoor by 30%

Fri, 20 Feb 2026 09:04:57 -0500

SRX Health Solutions raises stake in Opendoor by 30%

Form 4 Opendoor Technologies For: Feb 17 Filed by: Bain Adam

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031373.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Bain Adam

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031373.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Feder Eric

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031374.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Feder Eric

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031374.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Rabois Keith

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031377.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Rabois Keith

Thu, 19 Feb 2026 17:58:00 -0500

si-local-file:///var/storage/secattach/20260219/26031377.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Schwartz Christina

Thu, 19 Feb 2026 17:55:00 -0500

si-local-file:///var/storage/secattach/20260219/26031366.html

Form 4 Opendoor Technologies For: Feb 17 Filed by: Schwartz Christina

Thu, 19 Feb 2026 17:55:00 -0500

si-local-file:///var/storage/secattach/20260219/26031366.html

Form 144 Opendoor Technologies Filed by: Schwartz Christina

Thu, 19 Feb 2026 17:51:00 -0500

si-local-file:///var/storage/secattach/20260219/26031351.html

Form 144 Opendoor Technologies Filed by: Schwartz Christina

Thu, 19 Feb 2026 17:51:00 -0500

si-local-file:///var/storage/secattach/20260219/26031351.html

Opendoor stock rallies on 46% jump in home acquisition volume

Thu, 19 Feb 2026 16:34:51 -0500

Investing.com -- Opendoor Technologies Inc (NASDAQ:OPEN) shares jumped 13.1% in after-hours trade Thursday trading as investors brushed off a significant bottom-line miss to focus on accelerating acquisition volumes. The San Francisco-based iBuyer is attempting to pivot its business model toward higher velocity and lower capital intensity amid a volatile housing market.

The company reported a fourth-quarter loss of $1.26 per share, trailing the analyst consensus estimate of a $0.12 loss by a wide margin. However, revenue reached $736 million for the period, comfortably exceeding the $576.94 million anticipated by Wall

Opendoor stock rallies on 46% jump in home acquisition volume

Thu, 19 Feb 2026 16:34:51 -0500

Investing.com -- Opendoor Technologies Inc (NASDAQ:OPEN) shares jumped 13.1% in after-hours trade Thursday trading as investors brushed off a significant bottom-line miss to focus on accelerating acquisition volumes. The San Francisco-based iBuyer is attempting to pivot its business model toward higher velocity and lower capital intensity amid a volatile housing market.

The company reported a fourth-quarter loss of $1.26 per share, trailing the analyst consensus estimate of a $0.12 loss by a wide margin. However, revenue reached $736 million for the period, comfortably exceeding the $576.94 million anticipated by Wall

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736

After-hours movers: Akamai, Opendoor, GRAIL and more

Thu, 19 Feb 2026 16:34:21 -0500

After-hours movers:

Akamai Technologies (NASDAQ: AKAM) fell 9% despite matching quarter EPS and revenue estimates, after it issue guidance that tailed consensus. Akamai Technologies sees FY2026 EPS of $6.20-$7.20, versus the consensus of $7.34.

GRAIL, Inc. (NASDAQ: GRAL) dropped 30% after its cancer screening test showed mixed results. The primary endpoint of statistically significant Stage III-IV reduction was not observed. However, there was a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers in the intervention arm after the prevalent screening round.

Opendoor (NASDAQ: OPEN) rose 12% after revenue for the quarter came in at $736